• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Glynis Ablon, MD, Previews IMCAS World Congress 2024

Feature
Article

Ablon’s session highlights include best practices for hair restoration.

At the upcoming IMCAS World Congress 2024 meeting in Paris, France, Glynis Ablon, MD, board-certified dermatologist, associate clinical professor of dermatology at the University of California, Los Angeles, and owner of the Ablon Skin Institute and Research Center in Manhattan Beach, California, will present her best clinical pearls for hair restoration.

Ablon’s session, “Ethics of Hair Loss Treatments,” will explore the multifactorial aspects of hair loss, the need for physicians to be aware of all treatment options available, and keeping up-to-date with current research.

“I think it is through scientific research, clinical trials, and data that we can evaluate different options that either support or deny treatment development and what works for the patient,” said Ablon.

Transcript

Glynis Ablon, MD: Hi, I'm Dr. Glynis Ablon. I'm a board-certified dermatologist in Manhattan Beach, California, I run the Ablon Skin Institute and Research Center, and I'm an associate professor at UCLA.

Dermatology Times: Could you please discuss the significance of the IMCAS conference bringing so many world-renowned physicians together?

Ablon: IMCAS is one of the largest medical aesthetic conferences in the world. It really does bring aesthetic physicians, dermatologists, and plastic surgeons from all over the world and with different backgrounds, and we can share our scientific contributions, our new technologies, new trends or current trends, and corporate developments in a stimulating, diverse medical community.

Dermatology Times: What are 3 top pearls you hope attendees take away from your session, "Ethics of Hair Loss Treatment?"

Ablon: The top 3 points from my session on hair loss are number one, you have to remember that hair loss is multifactorial, and only a portion of it is genetic. It's really imperative to look for all the possible etiologies that affect an individual with hair loss. That includes people who have environmental exposures, stress, and hormones, there are so many different things to discuss. I really do love questionnaires for that for my patients. Number two, I'd say as physicians, you have to be aware of all the treatment options that are out there because a lot of patients will come in knowing what they want. So you really need to know what's out there, how they work and what the number of sessions are, the price, clinical success, complications, and all of that information is really giving you an ethical approach to hair loss for each individual patient. The third thing really is to understand the research and data that's out there for each treatment option, and that combination treatment oftentimes works best, and we get the most results for those patients.

Dermatology Times: Your session is part of the larger "Hair Restoration: Medical" track. How are you and your fellow presenters bringing new data to your dermatology community to best serve patients?

Ablon: I recently published an article a couple of years ago on looking at the ethics of hair loss with Dr. Nestor and his team. It's really important; I'm finishing 4 clinical trials for hair loss supplements currently. And like my colleagues, I think it really is through scientific research, clinical trials, and data that we can really evaluate different options that either support or deny treatment development and what really works for the patient.

[Transcript lighted edited for space and clarity.]

Related Videos
© 2024 MJH Life Sciences

All rights reserved.